TokenPost topic

Corcept Therapeutics

1 TokenPost story is tagged Corcept Therapeutics. The newest appear first.

Latest Corcept Therapeutics stories

• Corcept Ties $3B-$5B Cushing’s Revenue Outlook to Relacorilant

  The current Cushing’s syndrome business could generate at least $2 billion in annual revenue by decade’s end. The FDA is expected to decide on relacorilant by Dec. 17, 2026.

  Nov 4, 2026, 6:44 AM EST · Business